Krystal Biotech Inc. logo

Krystal Biotech Inc.

KRYS | NASDAQ
Chart Builder DCF Calculator
$333.85
-$2.82 (-0.84%)
At close: Sep 21, 2026, 4:00 PM ET
$333.85
$0 (0.00%)
After-hours: Sep 21, 2026, 7:30 PM ET
Fiscal Quarter
Period Ending
Q2 2026
Jun 29, 2026
Q1 2026
Mar 30, 2026
Q4 2025
Dec 30, 2025
Q3 2025
Sep 29, 2025
Q2 2025
Jun 29, 2025
Q1 2025
Mar 30, 2025
Q4 2024
Dec 30, 2024
Q3 2024
Sep 29, 2024
Q2 2024
Jun 29, 2024
Q1 2024
Mar 30, 2024
Q4 2023
Dec 30, 2023
Q3 2023
Sep 29, 2023
Q2 2023
Jun 29, 2023
Q1 2023
Mar 30, 2023
Q4 2022
Dec 30, 2022
Q3 2022
Sep 29, 2022
Q2 2022
Jun 29, 2022
Q1 2022
Mar 30, 2022
Q4 2021
Dec 30, 2021
Q3 2021
Sep 29, 2021
Q2 2021
Jun 29, 2021
Q1 2021
Mar 30, 2021
Revenue
119.22M 116.36M 107.11M 97.8M 96.04M 88.18M 91.14M 83.84M 70.28M 45.25M 42.14M 8.56M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost of Revenue
6.44M 6.32M 10.92M 5.66M 7.17M 5.03M 4.95M 6.68M 6.01M 2.42M 4.38M 223K n/a n/a n/a n/a n/a 1.01M n/a n/a n/a n/a
Gross Profit
112.79M 110.03M 96.19M 92.14M 88.88M 83.16M 86.19M 77.16M 64.28M 42.83M 37.77M 8.33M n/a n/a n/a n/a n/a -1.01M n/a n/a n/a n/a
Operating Income
58.42M 53.69M 44.44M 41.37M 39.31M 36.18M 41.38M 22.43M 8.57M -6.68M 3.14M -25.99M -38.05M -48.82M -34.77M -31.45M -28.75M -25.22M -21.88M -15.65M -16.39M -14.35M
Interest Income
7.66M 7.75M -14.06M 6.59M 7.47M 7.42M 7.23M 7.3M 7.48M 7.62M 7.52M 6.74M 4.84M 3.53M 2.72M 1.6M 645K 257K 70K 63K 30K 33K
Pretax Income
66.08M 61.44M 51.13M 47.97M 46.78M 43.6M 48.61M 29.77M 16.05M 932K 10.66M 80.75M -33.21M -45.3M -32.05M -29.85M -28.11M -49.97M -21.81M -15.59M -16.36M -15.81M
Net Income
54.77M 55.93M 51.4M 79.37M 38.33M 35.73M 45.48M 27.18M 15.57M 932K 8.69M 80.75M -33.21M -45.3M -32.05M -29.85M -28.11M -49.97M -21.81M -15.59M -16.36M -15.81M
Selling & General & Admin
39.85M 41.01M 41.28M 37.58M 35.16M 32.72M 31.29M 28.71M 27.63M 26.06M 23.26M 23.7M 25.9M 24.04M 24.03M 19.94M 17.86M 15.36M 12.87M 9.57M 9.8M 8.15M
Research & Development
14.52M 15.33M 16.2M 13.19M 14.41M 14.26M 13.52M 13.51M 15.58M 10.96M 11.37M 10.63M 12.14M 12.29M 10.74M 11.52M 10.89M 8.85M 9.01M 6.08M 6.59M 6.2M
Other Expenses
n/a n/a -5.72M n/a n/a n/a n/a 12.5M 12.5M 12.5M n/a n/a n/a 12.5M n/a n/a n/a n/a n/a n/a n/a n/a
Operating Expenses
54.37M 56.35M 51.75M 50.76M 49.57M 46.98M 44.81M 54.72M 55.71M 49.52M 34.63M 34.33M 38.05M 48.82M 34.77M 31.45M 28.75M 24.21M 21.88M 15.65M 16.39M 14.35M
Interest Expense
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 1.49M
Selling & Marketing Expenses
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a -50.38M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
60.81M 62.67M 62.67M 56.43M 56.74M 52.01M 49.76M 61.41M 61.72M 51.93M 39.01M 34.55M 38.05M 48.82M 34.77M 31.45M 28.75M 25.22M 21.88M 15.65M 16.39M 14.35M
Income Tax Expense
11.31M 5.51M -268K -31.4M 8.44M 7.86M 3.13M 2.59M 477K n/a 1.97M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Shares Outstanding (Basic)
29.53M 29.29M 28.94M 28.95M 28.91M 28.82M 28.76M 28.72M 28.6M 28.3M 28.17M 28.04M 26.66M 25.71M 25.56M 25.62M 25.55M 25.11M 22.2M 22.21M 22.2M 21.25M
Shares Outstanding (Diluted)
30.66M 30.51M 29.95M 29.83M 29.75M 29.87M 29.88M 29.9M 29.64M 29.29M 28.82M 28.89M 26.66M 25.71M 25.56M 25.62M 25.55M 25.11M 22.2M 22.21M 22.2M 21.25M
EPS (Basic)
1.85 1.91 1.77 2.74 1.33 1.24 1.58 0.95 0.54 0.03 0.31 2.88 -1.25 -1.76 -1.25 -1.17 -1.10 -1.99 -0.98 -0.70 -0.74 -0.74
EPS (Diluted)
1.79 1.83 1.70 2.66 1.29 1.20 1.52 0.91 0.53 0.03 0.30 2.79 -1.25 -1.76 -1.25 -1.17 -1.10 -1.99 -0.98 -0.70 -0.74 -0.74
EBITDA
66.08M 63.17M 39.61M 49.58M 48.32M 45.23M 50.17M 36.46M 23.09M 7.43M 12.16M 82.11M -31.73M -35.01M -30.96M -28.88M -27.13M -48.95M -21.02M -14.81M -15.7M -13.78M
EBIT
66.08M 61.44M 37.84M 47.97M 46.78M 43.6M 48.61M 34.93M 21.07M 5.82M 10.66M 80.75M -33.21M -36.32M -32.05M -29.85M -28.11M -49.97M -21.81M -15.59M -16.36M -14.32M
Depreciation & Amortization
n/a 1.73M 1.77M 1.61M 1.54M 1.63M 1.56M 1.53M 2.02M 1.61M 1.51M 1.37M 1.48M 1.31M 1.09M 975K 976K 1.01M 784K 783K 666K 536K

© 2026 bestshares.com. All rights reserved.